Impact of chemotherapy (CT) in heavily pretreated BRCA1/2 mutation carrier ovarian cancer (BMCOC) patients (pts)
Por:
Freixinos, VR, Madrid, LF, Martin, MG, Barretina, P, Marin, MR, Javierre, GV, Viaplana, C, Pardo, B, Ouahid, HA, Recalde, S, Rodriguez, JMP, Gomez, MC, Gil-Moreno, A, Sala, E, Martinez-Roman, S, Melendez, C, Carballas, E, Dienstmann, R and Oaknin, A
Publicada:
1 sep 2017
Resumen:
Filiaciones:
Freixinos, VR:
Vall dHebron Univ Hosp, Dept Med Oncol, Vall dHebron Inst Oncol VHIO, Barcelona, Spain
Madrid, LF:
Vall dHebron Univ Hosp, Dept Med Oncol, Vall dHebron Inst Oncol VHIO, Barcelona, Spain
Martin, MG:
Inst Catala Oncol, Med Oncol, Barcelona, Spain
Barretina, P:
Hosp Univ Josep Trueta, Med Oncol, ICO, Girona, Spain
:
Hosp Badalona Germans Trias & Pujol, Med Oncol, Catalan Inst Oncol ICO Badalona, Badalona, Spain
Javierre, GV:
Vall dHebron Inst Oncol, Oncol Data Sci ODysSey, Barcelona, Spain
Viaplana, C:
Vall dHebron Inst Oncol VHIO, Oncol Data Sci Grp ODysSey, Barcelona, Spain
Pardo, B:
Inst Catala Oncol, Med Oncol, Barcelona, Spain
Ouahid, HA:
Hosp Univ Josep Trueta, Med Oncol, ICO, Girona, Spain
Recalde, S:
Catalan Inst Oncol, Med Oncol, Lhospitalet De Llobregat, Spain
Rodriguez, JMP:
Inst Catala Oncol, Med Oncol, Barcelona, Spain
:
Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol ICO Badalona, Dept Pathol, Badalona, Spain
Gil-Moreno, A:
Vall dHebron Univ Hosp, Gynaecol, Barcelona, Spain
Sala, E:
Hosp Univ Josep Trueta, ICO, Gynaecol, Girona, Spain
Martinez-Roman, S:
Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol ICO Badalona, Gynaecol, Badalona, Spain
Melendez, C:
Hosp Univ Josep Trueta, Med Oncol, ICO, Girona, Spain
Carballas, E:
Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol ICO Badalona, Gynaecol, Badalona, Spain
Dienstmann, R:
Vall dHebron Univ Hosp, Oncol Data Sci ODysSey Grp, Barcelona, Spain
Oaknin, A:
Vall dHebron Univ Hosp, Dept Med Oncol, Vall dHebron Inst Oncol VHIO, Barcelona, Spain
|